Press Releases

Jun 1, 2018

PharmaCyte Biotech Receives Certificates of Analysis from Eurofins on Cells Used for Pancreatic Cancer Therapy

May 30, 2018

PharmaCyte Biotech CEO and CSO Interviewed About IND, Planned Clinical Trial in Pancreatic Cancer, CRO and More

May 16, 2018

PharmaCyte Biotech Successfully Completes 29 Tests Conducted on Live Cells Used in Pancreatic Cancer Therapy

May 9, 2018

PharmaCyte Biotech Successfully Completes Pore Size Studies in Cell-in-a-Box® Capsules Used in Pancreatic Cancer Therapy

Apr 30, 2018

PharmaCyte Biotech Reports Successful Completion of Long-term Studies on Cells Used in Pancreatic Cancer Therapy

Apr 17, 2018

PharmaCyte Biotech Successfully Completes Multiple Course Ifosfamide Study

Apr 5, 2018

PharmaCyte’s Clinical Trial Cells Arrive Safely at Austrianova’s Encapsulation Facility

Apr 2, 2018

PharmaCyte Ships Clinical Trial Cells to Austrianova for Encapsulation

Mar 26, 2018

PharmaCyte Biotech Files Patent Applications to Broaden Protection of Cancer Therapy in U.S. and Worldwide

Feb 28, 2018

PharmaCyte Discusses Phase 2b Clinical Trial in Pancreatic Cancer